In this review:
The 11th Annual South GP CME Meeting took place using an online format in August 2020. Professor Richard Troughton from Christchurch Hospital and the Christchurch Heart Institute spoke at a breakfast symposium sponsored by Novartis (NZ) Ltd. Professor Troughton provided an overview of heart failure, focusing on what GPs need to know to provide gold standard treatment. He also reviewed evidence for the use of sacubitril/valsartan (Entresto®) in heart failure patients with reduced ejection fraction, an important treatment advance for this condition. This review summarises key points of Professor Troughton’s presentation.
Download PDF